Literature DB >> 22402417

Comparison of two-dimensional and real-time three-dimensional transesophageal echocardiography in the assessment of aortic valve area.

Atsuko Furukawa1, Yukio Abe, Chiharu Tanaka, Kazato Ito, Isao Tabuchi, Kazuhiro Osawa, Naoto Kino, Eiichiro Nakagawa, Ryushi Komatsu, Kazuo Haze, Minoru Yoshiyama, Junichi Yoshikawa, Takahiko Naruko, Akira Itoh.   

Abstract

BACKGROUND: The accuracy of two-dimensional transesophageal echocardiography (2D-TEE) for the measurement of aortic valve area (AVA) in patients with aortic stenosis (AS) depends upon the cross-section selected for imaging. Real-time three-dimensional transesophageal echocardiography (3D-TEE) may overcome this limitation of 2D-TEE. The goal of this study was to compare 3D-TEE with 2D-TEE for the measurement of AVA. METHODS AND
RESULTS: Twenty-five patients with AS underwent TEE. In 2D-TEE, the aortic valve image was obtained at the orifice level in the short-axis view, and AVA was measured by planimetry of the acquired images (2D-AVA). In 3D-TEE, 3D data containing the entire aortic valve were obtained. Then, a short-axis cross-section containing the smallest orifice in mid-systole was cut from the 3D data during image postprocessing, and the AVA was measured by planimetry (3D-AVA). The 3D-AVA was significantly smaller than the 2D-AVA (0.79±0.35cm(2) vs. 0.93±0.40cm(2), p<0.0001), but there was a strong correlation between 3D-AVA and 2D-AVA (R=0.94). Although the frame rate was lower in 3D-TEE than in 2D-TEE (17±6Hz vs. 58±16Hz), the 3D-AVA determined at each frame during systole showed that the difference between 3D-AVA and 2D-AVA was not explained by the lower frame rate. The time required for image acquisition of the aortic valve was shorter with 3D-TEE than with 2D-TEE (p=0.0005).
CONCLUSIONS: The geometric AVA is smaller with 3D-TEE than with 2D-TEE, and the difference is not due to the lower frame rate of 3D-TEE. The improved accuracy of 3D-TEE along with reduced image acquisition time indicates that 3D-TEE is superior to 2D-TEE for the assessment of AVA.
Copyright © 2012 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22402417     DOI: 10.1016/j.jjcc.2012.01.011

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  6 in total

1.  Grading of aortic stenosis severity: a head-to-head comparison between cardiac magnetic resonance imaging and echocardiography.

Authors:  Cesare Mantini; Gabriele Di Giammarco; Jacopo Pizzicannella; Sabina Gallina; Fabrizio Ricci; Emilia D'Ugo; Marziale Marchetti; Antonio Raffaele Cotroneo; Nauman Ahmed; Chiara Bucciarelli-Ducci; Armando Tartaro; Raffaele De Caterina
Journal:  Radiol Med       Date:  2018-05-05       Impact factor: 3.469

Review 2.  [Application fields of intraoperative transesophageal 3D echocardiography].

Authors:  H Magunia; P Rosenberger
Journal:  Anaesthesist       Date:  2014-09       Impact factor: 1.041

Review 3.  The mystery of defining aortic valve area: what have we learnt from three-dimensional imaging modalities?

Authors:  Ebraham Alskaf; Attila Kardos
Journal:  J Echocardiogr       Date:  2018-02-23

Review 4.  Role of modern 3D echocardiography in valvular heart disease.

Authors:  Takahiro Shiota
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

5.  Usefulness of Three-Dimensional Transthoracic Echocardiographic Planimetry in a 4-Month-Old Infant with Comorbid Aortic Stenosis and Coarctation of the Aorta Complicated with Low Left Ventricular Ejection Fraction.

Authors:  Junpei Kawamura; Kentaro Ueno; Yoshihiro Takahashi; Naohiro Shiokawa; Daisuke Hazeki; Yasuhiro Okamoto
Journal:  CASE (Phila)       Date:  2022-07-02

6.  Intraoperative three-dimensional transesophageal echocardiography for evaluating an unusual structure in the left ventricular outflow tract: a case report.

Authors:  Tae-Yun Sung; Won-Kyoung Kwon; Dong-Ho Park; Cheol-Hwan Park; Tae-Yop Kim
Journal:  Korean J Anesthesiol       Date:  2015-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.